COVID-19 disease and vaccination in pregnant and lactating women.

ABSTRACT:

Background

More than 325,000 cases of coronavirus disease 2019 (COVID-19) have been reported among pregnant women in the Americas.

Aims

This review examines the impact of COVID-19 in pregnant women and describes available evidence on the safety, effectiveness, and immune response(s) to vaccination among pregnant and lactating women.

Content

Multiple studies indicate that pregnant women are more susceptible to adverse COVID-19 outcomes, including hospitalization, intensive care unit admission, and invasive ventilation than non-pregnant women with COVID-19. Furthermore, COVID-19 in pregnancy is associated with adverse maternal and neonatal outcomes. Adverse COVID-19 outcomes appear to disproportionately affect pregnant women from low- and middle-income countries, likely

SUBMITTER: Safadi MAP 

PROVIDER: S-EPMC9111214 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature